1. Home
  2. BILL vs BLCO Comparison

BILL vs BLCO Comparison

Compare BILL & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BILL
  • BLCO
  • Stock Information
  • Founded
  • BILL 2006
  • BLCO 1853
  • Country
  • BILL United States
  • BLCO Canada
  • Employees
  • BILL N/A
  • BLCO N/A
  • Industry
  • BILL EDP Services
  • BLCO Ophthalmic Goods
  • Sector
  • BILL Technology
  • BLCO Health Care
  • Exchange
  • BILL Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • BILL 4.8B
  • BLCO 4.9B
  • IPO Year
  • BILL 2019
  • BLCO 2022
  • Fundamental
  • Price
  • BILL $45.30
  • BLCO $13.72
  • Analyst Decision
  • BILL Buy
  • BLCO Hold
  • Analyst Count
  • BILL 23
  • BLCO 12
  • Target Price
  • BILL $63.43
  • BLCO $15.55
  • AVG Volume (30 Days)
  • BILL 1.7M
  • BLCO 825.4K
  • Earning Date
  • BILL 08-21-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • BILL N/A
  • BLCO N/A
  • EPS Growth
  • BILL N/A
  • BLCO N/A
  • EPS
  • BILL N/A
  • BLCO N/A
  • Revenue
  • BILL $1,422,885,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • BILL $15.18
  • BLCO $7.10
  • Revenue Next Year
  • BILL $12.31
  • BLCO $5.50
  • P/E Ratio
  • BILL N/A
  • BLCO N/A
  • Revenue Growth
  • BILL 14.52
  • BLCO 11.94
  • 52 Week Low
  • BILL $36.55
  • BLCO $10.45
  • 52 Week High
  • BILL $100.19
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • BILL 47.92
  • BLCO 51.06
  • Support Level
  • BILL $44.97
  • BLCO $13.81
  • Resistance Level
  • BILL $46.86
  • BLCO $14.49
  • Average True Range (ATR)
  • BILL 1.48
  • BLCO 0.50
  • MACD
  • BILL -0.17
  • BLCO -0.05
  • Stochastic Oscillator
  • BILL 34.00
  • BLCO 8.44

About BILL BILL Holdings Inc.

BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: